• The document is a transcript of the Q1 & FY 2027 Financial Results earnings conference call held on August 6, 2026, submitted to the National Stock Exchange of India Limited.
  • The conference call was moderated by Mr. Aakash Maji from IIFL Capital. Management participants included Mr. Maulik Mehta (Deputy Managing Director), Mr. Sanjay Upadhyay (Director (Finance) & Group CFO), and Mr. Somsekhar Nanda (CFO, Deepak Nitrite Limited).
  • The stated purpose of the call was to discuss the company's Q1 FY27 operating performance, financial results, and strategic growth plans, followed by an interactive Q&A session with analysts.
  • The meeting was held after the earnings announcement, as it discusses the already-published Q1 FY27 results. The investor presentation and financial statements had been shared with participants prior to the call.
  • The transcript includes a standard disclaimer that certain statements made during the call may be forward-looking in nature.
  • No specific indication was provided about making a presentation, earnings deck, transcript, or recording available, though the transcript itself was submitted to the exchange and is available on the company's website at https://www.godeepak.com/financial-result/.
  • The company did not explicitly state that no unpublished price sensitive information (UPSI) would be shared during the call.

Financial Highlights Discussed:

  • Consolidated Performance (Q1 FY27): Revenue from Operations: INR 2,592 crore (35% YoY growth, 22% QoQ growth); EBITDA: INR 554 crore (159% YoY growth, 45% QoQ growth) with margins at 21% (vs 11% in Q1 FY26 and 18% in Q4 FY26); Profit Before Tax (PBT): INR 468 crore (202% YoY growth, 55% QoQ growth); Profit After Tax (PAT): INR 345 crore (207% YoY growth, 57% QoQ growth).
  • Segment Performance:
  • Phenolics: Revenue: INR 1,775 crore (36% YoY, 24% QoQ); EBIT: INR 418 crore (254% YoY, 46% QoQ) with margin of 24%.
  • Advanced Intermediates (AI): Revenue: INR 804 crore (33% YoY, 14% QoQ); EBIT: INR 67 crore (89% YoY, 100% QoQ) with margin of 8%.
  • Strategic Updates: The management highlighted the successful stabilization of the ammonia-to-amines integration chain. Projects including MIBK, MIBC, and acetophenone are on track for commissioning in August 2026 (current quarter), with the multipurpose agrochemical intermediates facility to follow within Q2 FY27.
  • Capex & Financing: The INR 11,500 crore integrated polycarbonate project (propylene to polycarbonate) is progressing. The entire debt for this project has been tied up at competitive rates (60:40 debt-to-equity ratio). Capex spent so far is ~INR 1,200 crore, with an additional INR 1,000-1,500 crore planned for FY27.
  • Guidance & Outlook: Management expressed optimism about the medium- and long-term outlook, citing improving demand, recently commissioned capacities, and expanding downstream offerings. They indicated confidence in delivering sustainable growth and superior earnings quality.

Additional Notes Section

  • The document is a submission to the NSE enclosing the earnings call transcript. The transcript itself is the primary attachment.
  • Significant financial data was disclosed and discussed in detail during the call, including revenue, EBITDA, PBT, PAT, and segment-wise breakdowns.
  • The transcript includes a full Q&A session with analysts from firms including Anvil Wealth, ICICI Securities, Nuvama Wealth, Antifragile Thinking, C.R. Kothari & Sons, 360 ONE Capital, Sunidhi Securities, Omega Portfolio Advisors, and JM Financial.
  • Logistical details like dial-in numbers were not included in the provided transcript.